To test whether miR-17 and miR-20b increased taxol-induced caspase 3 activities, we detected caspase 3 activities by fluorogenic substrate cleavage assays in breast cancer cells after treatment with miRNA mimics or inhibitors plus taxol. The gene discussed is CASP3; the disease is breast carcinoma.